On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 02/15/23
- Zillow Group: 'Things continue to be foggy'
- 12/08/22
- Zillow Group acquires real estate media marketing company VRX Media
- 01/24/23
- Zillow introduces feature enabling renters to schedule tours 'instantly, online'
- 01/19/23
- Redfin: Median U.S. home-sale price increased 0.9% for four weeks ending Jan. 15
- $212.17 /
+19.46 (+10.10%) - 02/27/23
- Union Pacific rises 11.3%
- 02/26/23
- Union Pacific CEO steps down, successor to be named in 2023
- 02/22/23
- North American rail traffic down 4% for the week ending February 18
- 02/15/23
- North American rail traffic down 4.3% for the week ending February 11
- 02/27/23
- Tegna falls -21.1%
- 02/27/23
- Standard General to challenge attempt to scuttle Tegna deal
- 02/27/23
- Tegna falls -23.6%
- 02/27/23
- Tegna falls -22.6%
- 02/14/23
- Taboola announces Taboola Turnkey Commerce launch in partnership with TIME
- 02/01/23
- Taboola announces experiments with integrating AI into ad platform
- 01/17/23
- Taboola and Yahoo close previously announced strategic pact
- 12/22/22
- Taboola announces early retirement of $61M in term loan debt
- 02/27/23
- Syneos Health jumps following report on new effort to sell itself
- 02/27/23
- Syneos Health trading resumes
- 02/27/23
- Syneos Health trading halted, volatility trading pause
- 02/08/23
- Syneos Health partners with Equicare, to accelerate clinical trial research
- 02/16/23
- Shell begins production at Vito in U.S. Gulf of Mexico
- 02/02/23
- Shell announces $4B share buyback program
- 01/30/23
- Shell announces changes to executive committee
- 01/24/23
- Shell PLC trading resumes
- 02/22/23
- Sangamo sees FY23 operating expenses of $275M-$295M
- 02/22/23
- Sangamo provides evidence of clinical benefit in Phase 1/2 STAAR study
- 10/12/22
- Sangamo announces updated preliminary STAAR study results
- 08/30/22
- Sangamo announces update from Phase 1/2 STAAR clinical study of ST-920
- $178.23 /
+17.2 (+10.68%) - 02/15/23
- Cellectar Biosciences hires Shustov as new Senior Vice President, Medical
- 02/13/23
- Seagen treatment of esophageal cancer granted orphan designation
- 01/19/23
- Seagen announces FDA accelerated approval of TUKYSA-trastuzumab combo
- 01/10/23
- Pieris Pharmaceuticals announces $5M milestone from Seagen
- 02/24/23
- Range Resources extends rally, shares up 15% to $29.01
- 02/24/23
- Range Resources trading resumes
RETA Reata Pharmaceuticals - $30.85 /
-13.63 (-30.64%) - 02/27/23
- Reata sinks after STAT reports Billy Dunn leaving FDA
- 11/08/22
- Reata sees cash and equivalents sufficient through end of 2024
- 10/13/22
- Reata Pharmaceuticals will not meet with FDA on NDA for omaveloxolone
- 09/22/22
- Point72 Asset Management reports 5.3% passive stake in Reata Pharmaceuticals
- 02/27/23
- Ready Capital falls -14.2%
- 02/27/23
- Ready Capital falls -14.0%
- 02/27/23
- Ready Capital falls -11.8%
- 02/27/23
- Ready Capital: Expected value at closing approximately $787M
RADI Radius Global Infrastructure - 02/27/23
- Radius Global shares jump 20% after Bloomberg report of EQT deal
- 02/27/23
- Radius Global Infrastructure trading resumes
- 02/27/23
- Radius Global Infrastructure trading halted, volatility trading pause
- 11/30/22
- Radius Global Infrastructure trading resumes
- 02/27/23
- Pioneer Natural says 'not contemplating a significant business combination'
- 02/24/23
- Range Resources higher, Pioneer Natural lower after report on possible tie-up
- 02/24/23
- Range Resources jumps 12% to $28.31 after report of Pioneer Natural interest
- 02/22/23
- Pioneer Natural sees FY23 Capital Budget $4.45B-$4.75B
- 02/24/23
- Pfizer treatment of pulmonary arterial hypertension gets FDA orphan designation
- 02/22/23
- Pfizer's elranatamab receives FDA and EMA filing acceptance
- 02/21/23
- Pfizer: FDA accepts for review BLA for RSV vaccine candidate
- 02/16/23
- Pfizer announces TALZENNA, XTANDI combination data from TALAPRO-2 study
OPEN Opendoor Technologies - 02/14/23
- Opendoor Technologies announces inducement grants under Nasdaq listing rule
- 01/05/23
- Redfin: Pending U.S. home sales dropped 32% y/y during four weeks ending Jan1
- 12/01/22
- Opendoor names CFO Carrie Wheeler CEO
- 11/14/22
- Opendoor Technologies director sells $8.9M in common stock
- 01/24/23
- Altria Group trading resumes
- 01/24/23
- Altria Group trading halted, volatility trading pause
- 01/22/23
- Fly Intel: Top five weekend stock stories
- 12/19/22
- Cronos Group receives notice of relinquishment of warrant by Altria Group
- 02/27/23
- Krispy Kreme confirms expanded market test with McDonald's
- 01/31/23
- McDonald's plans to open 1900 new restaurants in FY23 on gross basis
- 01/31/23
- McDonald's reports Q4 U.S. SSS up 10.3%
- 01/24/23
- NYSE sees unusual number of halted stocks at open due to exchange issues
- 02/27/23
- Li-Cycle receives conditional commitment for $375M loan
- 01/25/23
- Li-Cycle falls -9.9%
- 01/25/23
- Li-Cycle falls -9.6%
- 01/25/23
- Li-Cycle falls -10.3%
- 02/08/23
- Li Auto launches Li L7, a five-seat flagship family SUV
- 02/01/23
- Li Auto delivers 15,141 vehicles in January
- 01/02/23
- Fly Intel: Top five weekend stock stories
- 01/01/23
- Li Auto reports December deliveries up 50.7% to 21,233 vehicles
- 01/23/23
- Kosmos' floating vessel for GTA liquified natural gas project begins voyage
- 09/27/22
- Kosmos provides update on Greater Tortue Ahmeyim project FPSO
ICE IntercontinentalExchange - 02/27/23
- Black Knight down 5% after Politico says FTC to challenge deal
- 02/22/23
- IntercontinentalExchange selects Dow Jones as main provider of news content
- 02/02/23
- IntercontinentalExchange boosts dividend 11% to 42c per share
- 01/27/23
- IntercontinentalExchange to implement EU MCM Regulation on TTF derivatives
- 12/21/22
- FuboTV, Sinclair Broadcast announce carriage agreement for 19 RSNs
- 12/19/22
- FuboTV announces carriage agreement with Scripps Networks
- 12/15/22
- FuboTV comments on targeted criminal cyber attack
- 11/30/22
- FuboTV, SMAC Productions to co-produce eight part football documentary
- 02/27/23
- Fisker rises 30.2%
- 02/27/23
- Fisker rises 22.2%
- 02/27/23
- Fisker rises 18.4%
- 02/27/23
- Fisker sees 2023 production up to 42,400 units
- 02/27/23
- Freyr Battery announces strategic mandate, milestone outlook
- 02/26/23
- Fly Intel: Top five weekend stock stories
- 01/25/23
- Freyr Battery falls -12.2%
- 01/25/23
- Freyr Battery falls -12.1%
- 12/15/22
- Krispy Kreme down 4% amid investor day presentations
- 10/18/22
- Krispy Kreme up 8% after reports of McDonald's testing donut sales partnership
- 09/26/22
- Krispy Kreme offers free coffee on National Coffee Day
BRMK Broadmark Realty Capital - 02/27/23
- Broadmark Realty Capital rises 12.9%
- 02/27/23
- Broadmark Realty Capital rises 17.0%
- 02/27/23
- Broadmark Realty Capital rises 21.5%
- $461,500.00 /
-0.03 (-0.00%) - 02/14/23
- Berkshire added more of top-holding Apple, Paramount in Q4
- 12/19/22
- Berkshire Hathaway announces Thomas Murphy, Jr. elected to board of directors
- 12/18/22
- Fly Intel: Top five weekend stock stories
- 11/20/22
- Fly Intel: Top five weekend stock stories
- 02/27/23
- Black Knight falls 5% to $59.85 after Politico says FTC to challenge buyout
- 02/16/23
- Black Knight adds Wolter Kluwer solutions to digital closing package
- 10/12/22
- Black Knight integrates Surefire, Servicing Digital solutions
- 02/27/23
- Vizio appoints Mike Mohan to board of directors
- 11/22/22
- Best Buy rises 9.5%
- 11/22/22
- Best Buy jumps 8% to $76.17 after Q3 earnings beat and comps outlook update
- 11/22/22
- Best Buy sees FY23 comparable sales down approximately 10%
- 01/04/23
- Hannon Armstrong Invests in a 1.3 GW renewables portfolio operated by AES
- 12/08/22
- Air Products, AES Corp. to invest $4B in new Texas green hydrogen facility
- 12/02/22
- AES Corp. raises quarterly dividend 5% to 16.59c per share
- 10/11/22
- AES Corp. dedicates 227 MW, 908 MWh of energy storage projects in California
- 02/27/23 Tudor Pickering
- Pioneer Natural upgraded to Buy from Hold at Tudor Pickering
- 02/27/23 Truist
- Pioneer Natural price target lowered to $229 from $243 at Truist
- 02/27/23 Susquehanna
- Pioneer Natural price target lowered to $266 from $286 at Susquehanna
- 01/24/23 Wells Fargo
- Pioneer Natural initiated with an Underweight at Wells Fargo
- 01/24/23 Wells Fargo
- Range Resources initiated with an Equal Weight at Wells Fargo
- 01/23/23 Benchmark
- Range Resources downgraded to Hold at Benchmark on buyback potential
- 01/23/23 Benchmark
- Range Resources downgraded to Hold from Buy at Benchmark
- 01/09/23 Mizuho
- Range Resources assumed with a Neutral at Mizuho
- 02/27/23 JPMorgan
- Pfizer acquisition of Seagen could add $7B in sales, says JPMorgan
- 02/07/23 Daiwa
- Pfizer upgraded to Outperform from Neutral at Daiwa
- 02/01/23 Barclays
- Pfizer price target lowered to $44 from $49 at Barclays
- 01/26/23 UBS
- UBS downgrades Pfizer, says COVID estimates need to drop
- $178.23 /
+17.2 (+10.68%) - 02/23/23 Needham
- Seagen price target raised to $178 from $160 at Needham
- 02/17/23 Truist
- Seagen price target raised to $152 from $135 at Truist
- 02/17/23 JMP Securities
- Seagen price target raised to $168 from $142 at JMP Securities
- 02/27/23 Benchmark
- FCC referring Tegna case to ALJ 'effectively kills' transaction, says Benchmark
- 02/26/23 Wells Fargo
- Wells cuts Tegna target, says FCC move likely 'deal killer'
- 06/06/22 Huber Research
- Tegna upgraded to Overweight from Underweight at Huber Research
- 05/05/22 Wells Fargo
- Wells Fargo downgrades Tegna to Equal Weight, ups price target to $24
- 02/28/23 Piper Sandler
- Ready Capital price target lowered to $12.50 from $13 at Piper Sandler
- 02/28/23 Piper Sandler
- Broadmark Realty upgraded to Neutral from Underweight at Piper Sandler
- 02/27/23 BTIG
- BTIG remains bullish on Ready Capital following news of merger with Broadmark
- 12/15/22 Keefe Bruyette
- Ready Capital downgraded to Market Perform from Outperform at Keefe Bruyette
BRMK Broadmark Realty Capital - 12/16/22 Piper Sandler
- Broadmark Realty Capital price target lowered to $3.75 from $5 at Piper Sandler
- $212.17 /
+19.46 (+10.10%) - 02/27/23 RBC Capital
- Union Pacific upgraded to Sector Perform at RBC amid activism
- 02/27/23 RBC Capital
- Union Pacific upgraded to Sector Perform from Underperform at RBC Capital
- 02/27/23 Stephens
- Activist adds 'another layer of pressure' on Union Pacific, says Stephens
- 02/27/23 JPMorgan
- Union Pacific will outperform on CEO change, says JPMorgan
- 02/28/23 AlphaValue/Baader
- Shell upgraded to Add from Reduce at AlphaValue/Baader
- 02/26/23 Goldman Sachs
- Shell upgraded to Buy from Neutral at Goldman Sachs
- 02/24/23 JPMorgan
- Shell price target raised to 3,000 GBp from 2,950 GBp at JPMorgan
- 02/17/23 Berenberg
- Shell price target raised to 3,000 GBp from 2,900 GBp at Berenberg
- 02/27/23 Wedbush
- Wedbush upgrades Sangamo to Outperform, raises price target to $16
- 02/27/23 Wedbush
- Sangamo upgraded to Outperform from Neutral at Wedbush
- 01/06/23 BofA
- Sangamo downgraded to Neutral from Buy at BofA
- 06/13/22 Wedbush
- Sangamo assumed with a Neutral, $5 price target at Wedbush
- 02/27/23 Telsey Advisory
- Telsey downgrades Best Buy on weakening consumer demand
- 02/27/23 Telsey Advisory
- Best Buy downgraded to Market Perform from Outperform at Telsey Advisory
- 02/24/23 UBS
- Best Buy price target raised to $87 from $80 at UBS
- 02/07/23 Barclays
- Barclays sees a 'reset' in U.S. retail but 'not a recession yet'
OPEN Opendoor Technologies - 02/27/23 Oppenheimer
- Opendoor Technologies downgraded to Perform from Outperform at Oppenheimer
- 02/14/23 Citi
- Opendoor Technologies price target raised to $2 from $1.50 at Citi
- 12/29/22 BTIG
- Opendoor Technologies valuation remains attractive, says BTIG
- 12/21/22 Truist
- Opendoor Technologies cut to Hold at Truist on high inventory, price correction
- 02/27/23 JPMorgan
- Zillow Group initiated with an Overweight at JPMorgan
- 02/17/23 DA Davidson
- Zillow Group price target raised to $54 from $41 at DA Davidson
- 02/17/23 Citi
- Zillow Group price target raised to $59 from $50 at Citi
- 02/16/23 Craig-Hallum
- Zillow Group price target raised to $58 from $38 at Craig-Hallum
- 02/16/23 Wedbush
- Zillow Group price target raised to $38 from $31 at Wedbush
- 02/13/23 Evercore ISI
- Zillow Group upgraded to Outperform at Evercore on five 'key factors'
- 02/27/23 Baird
- Baird sees more value in Syneos than market, but says buyer would 'need resolve'
- 02/17/23 Baird
- Syneos Health price target raised to $51 from $42 at Baird
- 02/13/23 JPMorgan
- Syneos Health downgraded to Underweight from Neutral at JPMorgan
- 01/17/23 Barclays
- Syneos Health downgraded to Underweight from Overweight at Barclays
- 02/24/23 Evercore ISI
- Domino's target lowered, removed from 'Tactical Underperform' list at Evercore
- 02/17/23 Loop Capital
- Loop Capital checks suggest accelerating same-store sales at McDonalds
- 02/03/23 RBC Capital
- McDonald's price target lowered to $283 from $296 at RBC Capital
- 02/01/23 Truist
- McDonald's price target lowered to $292 from $300 at Truist
- 02/14/23 HSBC
- Krispy Kreme price target lowered to $14 from $15 at HSBC
- 01/17/23 Morgan Stanley
- Krispy Kreme downgraded to Equal Weight from Overweight at Morgan Stanley
- 12/20/22 Deutsche Bank
- Krispy Kreme price target lowered to $13 from $15 at Deutsche Bank
- 11/16/22 CL King
- Krispy Kreme price target raised to $18 from $17 at CL King
- 11/10/22 UBS
- UBS downgrades Altria to Sell on consumer trade down risk
- 11/10/22 UBS
- Altria Group downgraded to Sell from Neutral at UBS
- 11/02/22 Morgan Stanley
- Philip Morris price target raised to $109 from $102 at Morgan Stanley
- 10/28/22 Stifel
- Altria JV news trumps 'rare' EPS miss, says Stifel
RADI Radius Global Infrastructure - 12/16/22 RBC Capital
- Radius Global Infrastructure initiated with a Sector Perform at RBC Capital
- 12/14/22 Exane BNP Paribas
- Radius Global Infrastructure initiated with an Outperform at Exane BNP Paribas
- 10/04/22 Raymond James
- Radius Global Infrastructure price target lowered to $17 from $21 at Raymond James
- 05/10/22 Raymond James
- Radius Global Infrastructure price target raised to $22 from $18 at Raymond James
ICE IntercontinentalExchange - 01/12/23 Citi
- IntercontinentalExchange price target raised to $110 from $102 at Citi
- 01/11/23 Deutsche Bank
- IntercontinentalExchange price target lowered to $131 from $134 at Deutsche Bank
- 12/06/22 Raymond James
- IntercontinentalExchange price target raised to $130 from $123 at Raymond James
- 11/17/22 BofA
- IntercontinentalExchange upgraded to Buy from Neutral at BofA
- 01/03/23 Stephens
- Castle Biosciences, Academy Sports on Stephens 'Best Ideas' list for 2023
- 12/02/22 Barclays
- Black Knight downgraded to Equal Weight from Overweight at Barclays
- 02/10/23 BofA
- BofA starts Freyr Battery with Buy on substantial opportunity
- 02/10/23 BofA
- Freyr Battery initiated with a Buy at BofA
- 01/25/23 Morgan Stanley
- Tesla price target lowered to $220, named 'Top Pick' at Morgan Stanley
- 01/25/23 Morgan Stanley
- Freyr Battery downgraded, price target halved at Morgan Stanley amid EV 'reset'
- 01/31/23 Baird
- Li-Cycle price target lowered to $7 from $8 at Baird
- 01/25/23 Morgan Stanley
- Li-Cycle downgraded to Underweight at Morgan Stanley amid EV 'reset'
- 01/25/23 Morgan Stanley
- Li-Cycle downgraded to Underweight from Equal Weight at Morgan Stanley
- 12/15/22 Citi
- Li-Cycle price target lowered to $7.50 from $8 at Citi
- 02/09/23 Benchmark
- Benchmark starts 'under-valued' Kosmos with a Buy
- 02/08/23 Benchmark
- Kosmos initiated with a Buy at Benchmark
- 11/09/22 Berenberg
- Kosmos price target raised to 735 GBp from 710 GBp at Berenberg
- 08/25/22 Berenberg
- Kosmos upgraded to Buy from Hold at Berenberg
- 02/27/23 TD Cowen
- Taboola price target raised to $6 from $5 at Cowen
- 11/14/22 Susquehanna
- Taboola price target lowered to $2.25 from $3.50 at Susquehanna
- 11/10/22 TD Cowen
- Taboola price target lowered to $5 from $6 at Cowen
- 11/08/22 TD Cowen
- Taboola price target lowered to $6 from $9 at Cowen
- $461,500.00 /
-0.03 (-0.00%) - 02/26/23 Keefe Bruyette
- Berkshire price target lowered to $480,000 from $500,000 at Keefe Bruyette
- 02/07/23 UBS
- Berkshire can outperform given uncertain economy, says UBS
- 11/06/22 Keefe Bruyette
- Berkshire price target lowered to $495,000 from $500,000 at Keefe Bruyette
- 09/29/22
- Gordon Haskett says Berkshire buying of Occidental unlikely influenced by Chazen
- 09/21/22 Edward Jones
- Berkshire Hathaway upgraded to Buy from Hold at Edward Jones
- 08/23/22
- Berkshire largest Celanese holder behind Vanguard, says Gordon Haskett
- 06/23/22 Truist
- Truist ups Occidental target to 'Street high' $93, sees good odds of Buffett bid
- 05/01/22 Keefe Bruyette
- Berkshire price target lowered to $560,000 from $565,000 at Keefe Bruyette
- 02/14/23 Barclays
- Barclays starts autos and mobility sector, says Tesla stands out
- 02/14/23 Barclays
- Fisker initiated with an Underweight at Barclays
- 01/25/23 Morgan Stanley
- Fisker cut to Underweight, price target halved at Morgan Stanley
- 01/25/23 Morgan Stanley
- Fisker downgraded to Underweight from Equal Weight at Morgan Stanley
- 02/28/23 Barclays
- Li Auto price target raised to $31 from $25 at Barclays
- 02/09/23 Citi
- Li Auto price target raised to $51.50 from $48 at Citi
- 02/07/23 HSBC
- Li Auto price target lowered to $35 from $42 at HSBC
- 12/15/22 CLSA
- Li Auto price target lowered to $31 from $49 at CLSA
- 02/28/23 Evercore ISI
- FuboTV downgraded to In Line from Outperform at Evercore ISI
- 12/23/22 Needham
- FuboTV price target lowered to $3 from $4.50 at Needham
- 09/23/22 Wedbush
- FuboTV upgraded to Outperform from Neutral at Wedbush
- 09/23/22 Wedbush
- FuboTV upgraded to Outperform from Neutral at Wedbush
- 12/01/22 Argus
- AES Corp. price target raised to $31 from $29 at Argus
- 11/09/22 Citi
- AES Corp. price target raised to $30 from $27 at Citi
- 11/07/22 Susquehanna
- AES Corp. price target raised to $33 from $30 at Susquehanna
- 08/18/22 Morgan Stanley
- AES Corp. price target raised to $32 from $29.50 at Morgan Stanley
- 01/30/23 Deutsche Bank
- EQT AB price target lowered to SEK 290 from SEK 300 at Deutsche Bank
- 01/24/23 JPMorgan
- EQT AB price target lowered to SEK 207.30 from SEK 208.60 at JPMorgan
- 01/10/23 Barclays
- EQT AB price target lowered to SEK 300 from SEK 310 at Barclays
- 11/23/22 Morgan Stanley
- EQT AB resumed with an Equal Weight at Morgan Stanley
RETA Reata Pharmaceuticals - $30.85 /
-13.63 (-30.64%) - 02/27/23 Goldman Sachs
- Goldman maintains Buy rating on Reata after report of Dunn leaving FDA
- 02/27/23 Baird
- Reata pullback after Dunn departure from FDA 'isn't surprising,' says Baird
- 02/24/23 Goldman Sachs
- Reata Pharmaceuticals price target raised to $117 from $115 at Goldman Sachs
- 11/09/22 Citi
- Reata Pharmaceuticals price target raised to $53 from $51 at Citi
- 02/15/23
- Zillow reports Q4 adjusted EBITDA $73M
- 02/15/23
- Zillow Group sees Q1 revenue $404M-$437M, consensus $421.54M
- 02/15/23
- Notable companies reporting after market close
- 11/02/22
- Zillow Group sees Q4 revenue $395M-$425M, consensus $433.1M
- 02/15/23
- Zillow reports Q4 adjusted EBITDA $73M
- $212.17 /
+19.46 (+10.10%) - 01/24/23
- Union Pacific reports Q4 EPS $2.67, consensus $2.78
- 01/23/23
- Notable companies reporting before tomorrow's open
- 10/20/22
- Union Pacific reports Q3 EPS $3.19, consensus $3.06
- 02/27/23
- Tegna reports Q4 EPS 98c, consensus $1.13
- 11/09/22
- Tegna reports Q3 EPS 65c, consensus 73c
- 02/24/23
- Taboola sees FY24 adjusted EBITDA 'at least' $200M, $100M free cash flow
- 02/24/23
- Taboola sees FY23 revenue $1.42B-$1.47B, consensus $1.42B
- 02/24/23
- Taboola sees Q1 revenue $299M-$325M, consensus $325.93M
- 02/24/23
- Taboola reports Q4 adjusted EPS 16.4c, consensus 16c
- 02/16/23
- Syneos Health sees FY23 adjusted EPS $3.26-$3.53, consensus $3.89
- 02/16/23
- Syneos Health reports Q4 adjusted EPS $1.23, consensus $1.20
- 01/09/23
- Syneos Health backs FY22 EPS view $4.69-$4.87, consensus $4.70
- 11/04/22
- Syneos Health lowers FY22 adjusted EPS view to $4.69-$4.87 from $4.97-$5.11
- 02/02/23
- Shell reports Q4 adjusted EPS $1.39 vs. 83c last year
- 10/27/22
- Shell reports Q3 adjusted EPS $1.30 vs. 53c last year
- 02/22/23
- Sangamo reports Q4 EPS (32c), consensus (36c)
- 11/03/22
- Sangamo reports Q3 EPS (34c), consensus (35c)
- $178.23 /
+17.2 (+10.68%) - 02/15/23
- Seagen sees FY23 revenue $2.14B-$2.24B, consensus $2.3B
- 02/15/23
- Seagen reports Q4 EPS (80c), consensus ($1.04)
- 10/27/22
- Seagen raises FY22 revenue $1.82B-$1.865B from $1.71B-$1.795B
- 10/27/22
- Seagen reports Q3 EPS ($1.03), consensus (95c)
- 10/24/22
- Range Resources reports Q3 adjusted EPS $1.37, consensus $1.39
RETA Reata Pharmaceuticals - $30.85 /
-13.63 (-30.64%) - 11/08/22
- Reata Pharmaceuticals reports Q3 non-GAAP EPS ($1.47), consensus ($2.18)
- 02/27/23
- Ready Capital reports Q4 distributable EPS 40c, consensus 42c
- 11/07/22
- Ready Capital reports Q3 distributatble EPS 46c, consensus 45c
RADI Radius Global Infrastructure - 11/08/22
- Radius Global Infrastructure reports Q3 EPS 23c, consensus (26c)
- 02/22/23
- Pioneer Natural reports Q4 adjusted EPS $5.91, consensus $5.77
- 10/27/22
- Pioneer Natural reports Q3 adjusted EPS $7.48, consensus $7.50
- 01/31/23
- Pfizer sees FY23 adjusted EPS $3.25-$3.45, consensus $4.44
- 01/31/23
- Pfizer reports Q4 adjusted EPS $1.14, consensus $1.05
- 01/30/23
- Notable companies reporting before tomorrow's open
OPEN Opendoor Technologies - 02/23/23
- Opendoor Technologies sees Q1 revenue $2.45B-$2.65B, consensus $2.56B
- 02/23/23
- Opendoor Technologies reports Q4 EPS (63c), consensus (73c)
- 02/23/23
- Notable companies reporting after market close
- 11/03/22
- Opendoor Technologies sees Q4 revenue $2.3B-$2.5B, consensus $2.63B
- 02/01/23
- Altria Group sees FY23 adjusted EPS $4.98-$5.13, consensus $5.05
- 02/01/23
- Altria Group reports Q4 adjusted EPS $1.18, consensus $1.17
- 01/31/23
- Notable companies reporting before tomorrow's open
- 01/31/23
- McDonald's reports Q4 EPS $2.59, consensus $2.46
- 10/27/22
- McDonald's reports Q3 adjusted EPS $2.68, consensus $2.58
- 01/30/23
- Li-Cycle reports Q4 EPS (19c), consensus (17c)
- 09/14/22
- Li-Cycle reports Q3 EPS (16c), consensus (13c)
- 02/27/23
- Li Auto reports Q4 EPS 4c, consensus 2c
- 12/09/22
- Li Auto sees Q4 revenue $2.32B-$2.47B, consensus $2.55B
- 12/09/22
- Li Auto reports Q3 EPS (18c), consensus (15c)
- 02/27/23
- Kosmos reports Q4 adjusted EPS 23c, consensus 14c
- 11/07/22
- Kosmos reports Q3 EPS 47c vs. (7c) last year
ICE IntercontinentalExchange - 02/02/23
- IntercontinentalExchange reports Q4 EPS $1.25, consensus $1.26
- 11/03/22
- IntercontinentalExchange reports Q3 EPS $1.31, consensus $1.27
- 02/27/23
- FuboTV reports Q EPS (48c), consensus (71c)
- 02/27/23
- FuboTV sees FY23 revenue $1.2B-$1,23B, consensus $1.26B
- 02/27/23
- FuboTV sees Q1 revenue $ $295M-$300M , consensus $304.33M.
- 11/04/22
- FuboTV reports Q3 EPS (82c), consensus (73c)
- 02/27/23
- Fisker reports Q4 EPS (54c), consensus (42c)
- 11/02/22
- Fisker reports Q3 EPS (49c), consensus (43c)
- 02/27/23
- Freyr Battery reports Q4 EPS 20c, consensus (22c)
- 11/14/22
- Freyr Battery reports Q3 EPS (80c), consensus (30c)
- 02/15/23
- Krispy Kreme sees FY23 adjusted EPS 31c-34c, consensus 36c
- 02/15/23
- Krispy Kreme reports Q4 adjusted EPS 11c, consensus 10c
- 12/15/22
- Krispy Kreme sees FY26 revenue about $2.15B, adjusted EPS about 53c
- 12/15/22
- Krispy Kreme sees FY23 revenue up low double digits in constant currency
BRMK Broadmark Realty Capital - 02/27/23
- Broadmark Realty Capital reports Q4 distributable EPS 9c, consensus 12c
- 11/07/22
- Broadmark Realty Capital reports Q3 adjusted EPS 14c, consensus 16c
- 02/25/23
- Berkshire Hathaway reports Q4 operating earnings $6.71B vs. $7.29B last year
- $461,500.00 /
-0.03 (-0.00%) - 02/26/23
- Berkshire Hathaway Q4 operating earnings fall 8%, cash hoard tops $128B
- 11/05/22
- Berkshire Hathaway reports quarterly loss as operating earnings jump 20%
- 11/03/22
- Black Knight reports Q3 adjusted EPS 56c, consensus 66c
- 11/22/22
- Best Buy reports Q3 EPS $1.38, consensus $1.03
- 11/21/22
- Notable companies reporting before tomorrow's open
- 08/30/22
- Best Buy reports Q2 EPS$1.54, consensus $1.27
- 02/27/23
- AES Corp. sees FY23 EPS $1.65-$1.75, consensus $1.73
- 02/27/23
- AES Corp. reports Q4 adjusted EPS 49c, consensus 46c
- 11/04/22
- AES Corp. sees FY22 EPS at high end of $1.55-$1.65 range, consensus $1.61
- 11/04/22
- AES Corp. reports Q3 adjusted EPS 63c, consensus 53c
|